What is Tianjin Chase Sun Pharmaceutical Co.,Ltd's (300026.SZ) StockRank?

MoatMap's StockRank for Tianjin Chase Sun Pharmaceutical Co.,Ltd (300026.SZ) is 43/100, with a Hold signal. This is a composite score combining Quality (52), Value (40), and Momentum (43) factor ranks across MoatMap's 19,000+ stock universe.

Does Tianjin Chase Sun Pharmaceutical Co.,Ltd have an economic moat?

Tianjin Chase Sun Pharmaceutical Co.,Ltd (300026.SZ) has a Quality factor score of 52/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Tianjin Chase Sun Pharmaceutical Co.,Ltd a buy, hold, or sell?

MoatMap's current signal for Tianjin Chase Sun Pharmaceutical Co.,Ltd (300026.SZ) is Hold, based on a StockRank of 43/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Tianjin Chase Sun Pharmaceutical Co.,Ltd in?

Tianjin Chase Sun Pharmaceutical Co.,Ltd (300026.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

300026.SZ

HOLDREMOVE

Tianjin Chase Sun Pharmaceutical Co.,Ltd · Healthcare · China · $1.4B · Avg Vol: $11M/d

StockRank

P/E (TTM)

308.0x

ROE

0.3%

D/E

0.1x

Dividend %

0.3%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Tianjin Chase Sun is a Chinese pharmaceutical company focused on traditional Chinese medicine. It does not benefit from the high-moat CDMO pricing power cycle and lacks global scale.

COMPANY DESCRIPTION

Tianjin Chase Sun Pharmaceutical Co., Ltd. manufactures Chinese medicine formula granules, generic chemical drugs, and medical devices. The company is a dominant player in the highly regulated Chinese medicine formula granule market, benefiting from strict national licensing barriers and a vertically integrated supply chain from herb cultivation to clinical distribution. Its flagship cardiovascular injection, Xuebijing, further anchors its clinical market position.

FINANCIAL SUMMARY

Year	2021	2022	2023	2024	2025	CAGR
Revenue	1.1B	983M	903M	855M	—	-9.0%
EPS	—	0.03	0.03	0.00	0.00	-63.8%
Shares	3.0B	3.0B	3.0B	3.0B	—	0.0%
Debt	290M	309M	227M	126M	—	-24.3%
Equity	1.1B	1.2B	1.3B	1.3B	—	3.6%
Op CF	—	58M	110M	226M	126M	29.6%
Inv CF	—	-95M	-108M	-60M	-25M	—
Fin CF	—	69M	-22M	-114M	-142M	—

PRICE (1M)-11.6%

SMA 50SMA 200

$0.45

RSI (14)

35.1

52W High

$0.66

From 52W High

0.7%

SCORE BREAKDOWN

Quality

ROIC (ROA)

1.1%*46.5

ROE

0.3%45.7

GP/Assets

—N/A

Op. Margin

8.1%61.8

FCF/Assets

—N/A

Piotroski

—83.5

Int. Cover

—N/A

D/E Ratio

0.06x72.5

Current Ratio

4.70x68.6

Value

P/E (TTM)

308.0x3.0

EV/EBITDA

18.5x21.0

P/FCF

90.6x75.8

P/B

1.1x77.0

P/S

2.0x68.5

Div Yield

0.3%8.6

Momentum

52W High %

68%53.2

RS 6M

-29%42.9

SMA 50/200

0.92x40.7

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

9%50.6

FUNDAMENTALS

Market Cap

$1.4B

P/E (Forward)

7.5x

Gross Margin

57.1%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 300026.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
300026.SZ	Tianjin Chase Sun Pharmaceutical Co.,Ltd(you)	$1.4B	43	HOLD
002675.SZ	Yantai Dongcheng Pharmaceutical Group Co.,Ltd.	$1.6B	43	HOLD
000813.SZ	Dezhan Healthcare Company Limited	$1.0B	42	HOLD
600789.SS	Shandong Lukang Pharmaceutical Co.,Ltd.	$1.2B	48	HOLD
603538.SS	Ningbo Menovo Pharmaceutical Co., Ltd.	$1.6B	51	HOLD
600488.SS	Tianjin Tianyao Pharmaceuticals Co., Ltd.	$894M	40	HOLD
300267.SZ	Hunan Er-Kang Pharmaceutical Co., Ltd	$1.1B	34	SELL
688505.SS	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.	$1.1B	52	HOLD
002755.SZ	Beijing Aosaikang Pharmaceutical Co., Ltd.	$2.0B	35	HOLD
000534.SZ	Wedge Industrial Co.,Ltd.	$2.5B	39	HOLD

Peer medians: ROE 4.8% · P/E 27.6x · Gross margin 53.0%

Tianjin Chase Sun Pharmaceutical Co.,Ltd (300026.SZ) — Stock Score Summary

Tianjin Chase Sun Pharmaceutical Co.,Ltd (300026.SZ) has a MoatMap StockRank of 43/100 based on Quality (52/100), Value (40/100), and Momentum (43/100) factor scores. The current signal is HOLD. Tianjin Chase Sun is a Chinese pharmaceutical company focused on traditional Chinese medicine. It does not benefit from the high-moat CDMO pricing power cycle and lacks global scale.

Key Financial Metrics

Price	$0.45
Market Cap	$1.4B
P/E (TTM)	308.00
P/E (Forward)	7.51
Price/Book	1.08
Return on Equity	0.3%
Debt/Equity	5.92
Gross Margin	57.1%
Operating Margin	8.1%
Revenue Growth	-18.9%
Dividend Yield	0.3%
Free Cash Flow	$16M

Tianjin Chase Sun Pharmaceutical Co.,Ltd operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Tianjin Chase Sun Pharmaceutical Co.,Ltd’s (300026.SZ) StockRank?: MoatMap’s StockRank for Tianjin Chase Sun Pharmaceutical Co.,Ltd (300026.SZ) is 43/100, with a Hold signal. It is a composite of Quality (52), Value (40), and Momentum (43) factor ranks across MoatMap’s 19,000+ stock universe.
Does Tianjin Chase Sun Pharmaceutical Co.,Ltd have an economic moat?: Tianjin Chase Sun Pharmaceutical Co.,Ltd (300026.SZ) has a Quality factor score of 52/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Tianjin Chase Sun Pharmaceutical Co.,Ltd a buy, hold, or sell?: MoatMap’s current signal for Tianjin Chase Sun Pharmaceutical Co.,Ltd (300026.SZ) is Hold, based on a StockRank of 43/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Tianjin Chase Sun Pharmaceutical Co.,Ltd in?: Tianjin Chase Sun Pharmaceutical Co.,Ltd (300026.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).